About David Johnson
David Johnson is a director at Zentalis Pharmaceuticals.
Form D filings name David Johnson as a chief executive officer and director at Solve Therapeutics.
David Johnson reports to the SEC as a director of 2 public companies, including Aura Biosciences (AURA).
David Johnson first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name David Johnson in the role, so the role may have started earlier or lasted longer.
ZI
Zentalis Pharmaceuticals, Inc.
Director
2020 – 2026 · Public company (ZNTL)
AI
Aura Biosciences, Inc.
Director
2021 – 2026 · Public company (AURA)
Key Colleagues at Startups
The people David Johnson works with at each company, as listed on that company's latest Form D.
Solve Therapeutics, Inc. · Form D, Nov 25, 2025
DM
Daniel McHugh
Director
LM
Langdon Miller
Executive officer
CK
Clayton Knox
Executive officer
RM
Robert Mittendorff
Director
AC
Alan Colowick
Director
JP
Jason Pitts
Director
PC
Peter Colabuono
Director